Wenming Chen

12PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 16, 2026
Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

|Sep 10, 2026
A Multivariable Prediction Model for Early Mortality in Multiple Myeloma Patients With Renal Impairment.

|May 28, 2026
Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China.

|Apr 15, 2025
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Ya-Lan Zhou, Jin-Qiao Zhang, Wei Wang

|Apr 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study.

Aijun Liu, Hong Yu, Rui Hou

|Dec 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Huixing Zhou, Yafei Wang, Jiao Chen

Pageof 2

Frequent Collaborators

4 joint publications

Huixing Zhou

3 joint publications

Zhiyao Zhang

2 joint publications

Li Bao

2 joint publications

Yuan Jian